Post-transplant lymphoproliferative disorders: T-cell lymphoma following cardiac transplant

被引:16
|
作者
Haldas, J [1 ]
Wei, WB [1 ]
Lazarchick, J [1 ]
机构
[1] Med Univ S Carolina, Div Haematol & Oncol, Dept Med, Charleston, SC 29403 USA
关键词
PTLD; heart transplantation; T-cell lymphoma; immunosuppression; Epstein-Barr virus;
D O I
10.1080/10428190290006332
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Post-transplant lymphoproliferative disorders (PTLD) are a frequently fatal complication occurring after transplant. The majority of cases are of B-cell origin but a smaller percentage of cases are of T-cell origin. The etiology of these disorders is unclear, however, EBV (Epstein-Barr virus) in the context of immunosupperssion is thought to play a role, particularly in B-cell PTLD. We report a case of T-cell PTLD limited to the bone marrow occurring eight years post-cardiac transplantation and review the literature on T-cell PTLD after heart transplant.
引用
收藏
页码:447 / 450
页数:4
相关论文
共 50 条
  • [21] T-cell post-transplant lymphoproliferative disorder (PTLD) in children.
    Hunger, Stephen P.
    Yang, Fan
    Li, Ying
    Brayln, Raul
    Yang, Lijun
    PEDIATRIC TRANSPLANTATION, 2007, 11 : 62 - 63
  • [22] Post-transplant Lymphoproliferative Disorders (PTLD) in Kidney Transplant
    Campise, Mariarosaria
    Malvica, Silvia
    Alfieri, Carlo
    Verdesca, Simona
    Regalia, Anna
    Castellano, Giuseppe
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [23] T-Cell Post-Transplant Lymphoproliferative Disorder - A Single Center Experience
    Hill, M.
    Jie, T.
    Rezcallah, A.
    Aerts, J.
    Dunn, T.
    Kandaswamy, R.
    Matas, A.
    Humar, Abhinav
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 457 - 457
  • [24] Management of post-transplant lymphoproliferative disorders
    Dierickx, Daan
    Vergote, Vibeke
    HEMASPHERE, 2019, 3 : 74 - 77
  • [25] Management of post-transplant lymphoproliferative disorders
    DeStefano, Christin B.
    Desai, Sanjal H.
    Shenoy, Aarthi G.
    Catlett, Joseph P.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 (03) : 330 - 343
  • [26] Management of post-transplant lymphoproliferative disorders
    Llaurador, Gabriela
    McLaughlin, Lauren
    Wistinghausen, Birte
    CURRENT OPINION IN PEDIATRICS, 2017, 29 (01) : 34 - 40
  • [27] Oral bexarotene for post-transplant cutaneous T-cell lymphoma
    Lewis, Daniel J.
    Huang, Simo
    Duvic, Madeleine
    DERMATOLOGIC THERAPY, 2017, 30 (05)
  • [28] EBV-associated post-transplant lymphoproliferative disorders in T-cell depleted bone marrow transplant (BMT) patients.
    King, R
    Argani, P
    Papadopoulos, EB
    O'Reilly, RJ
    Ladanyi, M
    Filippa, DA
    MODERN PATHOLOGY, 1998, 11 (01) : 134A - 134A
  • [29] Post-transplant lymphoproliferative disorders following reduced intensity conditioning with in vivo T cell depletion -: Response
    Ho, AYL
    Devereux, S
    Pagliuca, A
    Mufti, GJ
    BONE MARROW TRANSPLANTATION, 2003, 31 (08) : 727 - 727
  • [30] Cancer risk following post-transplant lymphoproliferative disorders in solid organ transplant recipients
    Mahale, Parag
    Engels, Eric A.
    Lynch, Charles F.
    Morton, Lindsay M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 186 (02) : 347 - 351